| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gene Expression Regulation, Neoplastic | 119 | 2025 | 1937 | 7.650 |
Why?
|
| Gene Expression Profiling | 85 | 2025 | 1780 | 5.740 |
Why?
|
| Neoplasms | 35 | 2025 | 2838 | 5.370 |
Why?
|
| Breast Neoplasms | 58 | 2024 | 2587 | 4.280 |
Why?
|
| MicroRNAs | 60 | 2023 | 871 | 4.100 |
Why?
|
| Transcriptome | 37 | 2025 | 1064 | 3.970 |
Why?
|
| Genomic Structural Variation | 6 | 2025 | 92 | 3.750 |
Why?
|
| Prostatic Neoplasms | 38 | 2025 | 1392 | 3.320 |
Why?
|
| Biomarkers, Tumor | 36 | 2025 | 1570 | 3.260 |
Why?
|
| Lung Neoplasms | 47 | 2025 | 1486 | 3.250 |
Why?
|
| Carcinoma, Renal Cell | 15 | 2025 | 235 | 3.110 |
Why?
|
| Proteomics | 15 | 2025 | 563 | 3.100 |
Why?
|
| Genomics | 29 | 2025 | 1575 | 3.020 |
Why?
|
| DNA Methylation | 25 | 2025 | 1036 | 2.970 |
Why?
|
| Kidney Neoplasms | 16 | 2025 | 439 | 2.590 |
Why?
|
| Proteogenomics | 4 | 2025 | 107 | 2.530 |
Why?
|
| Cell Line, Tumor | 116 | 2025 | 3472 | 2.500 |
Why?
|
| Brain Neoplasms | 8 | 2025 | 1217 | 2.460 |
Why?
|
| Neoplasm Metastasis | 39 | 2025 | 682 | 2.320 |
Why?
|
| Signal Transduction | 87 | 2025 | 4462 | 2.120 |
Why?
|
| Genome, Human | 14 | 2021 | 1282 | 1.950 |
Why?
|
| Genes, Neoplasm | 5 | 2019 | 83 | 1.890 |
Why?
|
| Epithelial-Mesenchymal Transition | 24 | 2023 | 234 | 1.890 |
Why?
|
| Phosphatidylinositol 3-Kinases | 18 | 2022 | 328 | 1.820 |
Why?
|
| Humans | 298 | 2025 | 125950 | 1.730 |
Why?
|
| Ovarian Neoplasms | 13 | 2020 | 441 | 1.700 |
Why?
|
| Mass Spectrometry | 6 | 2025 | 351 | 1.690 |
Why?
|
| Proto-Oncogene Proteins c-akt | 15 | 2022 | 473 | 1.680 |
Why?
|
| Cell Proliferation | 66 | 2025 | 2390 | 1.650 |
Why?
|
| Proteome | 9 | 2025 | 274 | 1.620 |
Why?
|
| Mice | 158 | 2025 | 17590 | 1.620 |
Why?
|
| Adenocarcinoma | 24 | 2018 | 974 | 1.490 |
Why?
|
| Animals | 186 | 2025 | 33185 | 1.450 |
Why?
|
| CpG Islands | 7 | 2025 | 333 | 1.430 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 14 | 2023 | 27 | 1.420 |
Why?
|
| Mutation | 38 | 2025 | 5924 | 1.410 |
Why?
|
| Prostate | 17 | 2022 | 407 | 1.380 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 39 | 2018 | 1010 | 1.380 |
Why?
|
| Antineoplastic Agents | 13 | 2025 | 1751 | 1.300 |
Why?
|
| Gene Rearrangement | 3 | 2021 | 322 | 1.260 |
Why?
|
| TOR Serine-Threonine Kinases | 13 | 2022 | 415 | 1.240 |
Why?
|
| DNA Copy Number Variations | 12 | 2022 | 1005 | 1.220 |
Why?
|
| Databases, Genetic | 8 | 2021 | 482 | 1.180 |
Why?
|
| RNA, Messenger | 29 | 2023 | 2552 | 1.180 |
Why?
|
| Tumor Suppressor Protein p53 | 15 | 2022 | 722 | 1.140 |
Why?
|
| Epithelial Cells | 16 | 2022 | 871 | 1.120 |
Why?
|
| Drug Resistance, Neoplasm | 16 | 2021 | 770 | 1.120 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 10 | 2025 | 321 | 1.080 |
Why?
|
| Receptors, Estrogen | 16 | 2018 | 714 | 1.060 |
Why?
|
| Carcinogenesis | 14 | 2024 | 341 | 1.030 |
Why?
|
| Female | 148 | 2025 | 67908 | 1.030 |
Why?
|
| Triple Negative Breast Neoplasms | 8 | 2025 | 267 | 1.010 |
Why?
|
| PTEN Phosphohydrolase | 15 | 2022 | 252 | 0.990 |
Why?
|
| Germ-Line Mutation | 2 | 2025 | 352 | 0.990 |
Why?
|
| Receptors, Progesterone | 17 | 2021 | 664 | 0.970 |
Why?
|
| Mammary Glands, Animal | 14 | 2022 | 446 | 0.970 |
Why?
|
| Urinary Bladder Neoplasms | 4 | 2024 | 509 | 0.960 |
Why?
|
| Neoplasm Proteins | 9 | 2025 | 661 | 0.950 |
Why?
|
| Carcinoma, Squamous Cell | 10 | 2019 | 746 | 0.940 |
Why?
|
| Whole Genome Sequencing | 4 | 2021 | 323 | 0.940 |
Why?
|
| Epigenesis, Genetic | 12 | 2025 | 712 | 0.930 |
Why?
|
| Mice, Nude | 30 | 2025 | 707 | 0.910 |
Why?
|
| Transcription, Genetic | 15 | 2021 | 1381 | 0.910 |
Why?
|
| Xenograft Model Antitumor Assays | 27 | 2025 | 931 | 0.910 |
Why?
|
| Golgi Apparatus | 7 | 2025 | 90 | 0.890 |
Why?
|
| Cell Transformation, Neoplastic | 19 | 2024 | 607 | 0.880 |
Why?
|
| Sequence Analysis, RNA | 9 | 2021 | 416 | 0.870 |
Why?
|
| Estrogen Receptor alpha | 8 | 2018 | 419 | 0.840 |
Why?
|
| Stem Cells | 10 | 2024 | 678 | 0.840 |
Why?
|
| Cell Movement | 24 | 2025 | 845 | 0.810 |
Why?
|
| Neoplasm Recurrence, Local | 7 | 2021 | 1233 | 0.800 |
Why?
|
| Precision Medicine | 5 | 2022 | 346 | 0.760 |
Why?
|
| Transcription Factors | 19 | 2021 | 2346 | 0.760 |
Why?
|
| Mammary Neoplasms, Animal | 6 | 2022 | 132 | 0.760 |
Why?
|
| Prognosis | 32 | 2024 | 4691 | 0.760 |
Why?
|
| Tamoxifen | 9 | 2018 | 343 | 0.750 |
Why?
|
| RNA, Untranslated | 2 | 2021 | 109 | 0.750 |
Why?
|
| Membrane Proteins | 13 | 2025 | 1549 | 0.740 |
Why?
|
| Software | 5 | 2018 | 711 | 0.730 |
Why?
|
| Oncogenes | 7 | 2021 | 159 | 0.730 |
Why?
|
| Wnt Signaling Pathway | 11 | 2025 | 201 | 0.720 |
Why?
|
| Stromal Cells | 14 | 2022 | 299 | 0.720 |
Why?
|
| Cell Cycle Proteins | 8 | 2025 | 657 | 0.720 |
Why?
|
| Tumor Cells, Cultured | 18 | 2021 | 994 | 0.710 |
Why?
|
| MAP Kinase Kinase Kinase 2 | 1 | 2021 | 6 | 0.700 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2025 | 220 | 0.690 |
Why?
|
| Male | 89 | 2025 | 62094 | 0.680 |
Why?
|
| Cell Differentiation | 19 | 2024 | 1849 | 0.670 |
Why?
|
| Endometriosis | 7 | 2024 | 168 | 0.670 |
Why?
|
| Adaptor Proteins, Signal Transducing | 9 | 2025 | 571 | 0.670 |
Why?
|
| Computational Biology | 10 | 2021 | 839 | 0.660 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 276 | 0.650 |
Why?
|
| Sequence Analysis, DNA | 7 | 2020 | 1739 | 0.650 |
Why?
|
| Endometrium | 8 | 2023 | 265 | 0.640 |
Why?
|
| Receptors, Androgen | 9 | 2023 | 401 | 0.640 |
Why?
|
| Glioma | 6 | 2021 | 475 | 0.630 |
Why?
|
| COUP Transcription Factor II | 6 | 2021 | 96 | 0.620 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2021 | 247 | 0.620 |
Why?
|
| Protein Array Analysis | 5 | 2018 | 107 | 0.620 |
Why?
|
| Cystadenocarcinoma, Serous | 4 | 2020 | 46 | 0.610 |
Why?
|
| Ribonuclease III | 9 | 2020 | 102 | 0.610 |
Why?
|
| Proto-Oncogene Proteins c-myc | 6 | 2024 | 191 | 0.600 |
Why?
|
| Estradiol | 10 | 2020 | 475 | 0.590 |
Why?
|
| Uterus | 8 | 2023 | 533 | 0.590 |
Why?
|
| Transforming Growth Factor beta | 11 | 2021 | 448 | 0.590 |
Why?
|
| Disease Progression | 19 | 2021 | 2102 | 0.590 |
Why?
|
| Molecular Targeted Therapy | 7 | 2018 | 380 | 0.580 |
Why?
|
| Disease Models, Animal | 28 | 2023 | 4428 | 0.570 |
Why?
|
| Mice, SCID | 20 | 2022 | 565 | 0.570 |
Why?
|
| Protein Kinases | 4 | 2023 | 321 | 0.560 |
Why?
|
| Genes, Tumor Suppressor | 10 | 2020 | 200 | 0.560 |
Why?
|
| Embryo Implantation | 6 | 2021 | 223 | 0.550 |
Why?
|
| Progesterone | 9 | 2020 | 431 | 0.550 |
Why?
|
| Pathology, Molecular | 1 | 2018 | 62 | 0.550 |
Why?
|
| Apoptosis | 25 | 2023 | 1802 | 0.540 |
Why?
|
| Colonic Neoplasms | 3 | 2023 | 249 | 0.540 |
Why?
|
| Liposarcoma | 5 | 2017 | 25 | 0.530 |
Why?
|
| Uterine Neoplasms | 5 | 2019 | 103 | 0.520 |
Why?
|
| Receptor, ErbB-2 | 10 | 2018 | 509 | 0.520 |
Why?
|
| ErbB Receptors | 9 | 2021 | 286 | 0.520 |
Why?
|
| DEAD-box RNA Helicases | 8 | 2020 | 139 | 0.510 |
Why?
|
| RNA, Neoplasm | 8 | 2021 | 132 | 0.510 |
Why?
|
| Receptors, Notch | 7 | 2025 | 195 | 0.510 |
Why?
|
| Insulin-Like Growth Factor I | 5 | 2011 | 314 | 0.500 |
Why?
|
| Receptors, G-Protein-Coupled | 6 | 2024 | 291 | 0.490 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 22 | 2020 | 1236 | 0.490 |
Why?
|
| RNA Helicases | 3 | 2022 | 69 | 0.490 |
Why?
|
| Mice, Transgenic | 20 | 2023 | 2317 | 0.470 |
Why?
|
| Neoplastic Stem Cells | 7 | 2021 | 329 | 0.460 |
Why?
|
| Mitochondria | 4 | 2025 | 722 | 0.460 |
Why?
|
| Adenocarcinoma, Clear Cell | 3 | 2023 | 26 | 0.450 |
Why?
|
| Wnt Proteins | 4 | 2021 | 200 | 0.440 |
Why?
|
| Neoplasms, Experimental | 4 | 2019 | 204 | 0.440 |
Why?
|
| Cell Lineage | 6 | 2020 | 325 | 0.440 |
Why?
|
| Homeodomain Proteins | 7 | 2017 | 539 | 0.440 |
Why?
|
| Antineoplastic Agents, Hormonal | 5 | 2018 | 253 | 0.440 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 3 | 2024 | 110 | 0.440 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 10 | 2023 | 168 | 0.440 |
Why?
|
| Proteins | 3 | 2015 | 1019 | 0.430 |
Why?
|
| Pancreatic Neoplasms | 5 | 2024 | 704 | 0.430 |
Why?
|
| Receptor Tyrosine Kinase-like Orphan Receptors | 3 | 2022 | 36 | 0.430 |
Why?
|
| DNA Mutational Analysis | 7 | 2015 | 780 | 0.430 |
Why?
|
| Cell Transdifferentiation | 2 | 2016 | 59 | 0.430 |
Why?
|
| Colorectal Neoplasms | 5 | 2025 | 621 | 0.430 |
Why?
|
| Immunity | 3 | 2021 | 175 | 0.420 |
Why?
|
| Mitogen-Activated Protein Kinases | 4 | 2022 | 186 | 0.420 |
Why?
|
| Hormones | 2 | 2020 | 167 | 0.410 |
Why?
|
| Germ Cells | 2 | 2025 | 196 | 0.410 |
Why?
|
| Forkhead Transcription Factors | 5 | 2022 | 364 | 0.410 |
Why?
|
| Metabolic Networks and Pathways | 4 | 2019 | 193 | 0.410 |
Why?
|
| Gene Knockdown Techniques | 15 | 2025 | 372 | 0.400 |
Why?
|
| Mice, Knockout | 23 | 2021 | 3705 | 0.400 |
Why?
|
| Tumor Microenvironment | 11 | 2023 | 624 | 0.400 |
Why?
|
| Gene Expression Regulation | 15 | 2022 | 2330 | 0.400 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 3 | 2017 | 37 | 0.400 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2025 | 586 | 0.400 |
Why?
|
| Genes, p53 | 5 | 2020 | 213 | 0.400 |
Why?
|
| Carcinoma | 3 | 2013 | 282 | 0.400 |
Why?
|
| Neoplasm Invasiveness | 13 | 2021 | 636 | 0.400 |
Why?
|
| Down-Regulation | 14 | 2017 | 651 | 0.390 |
Why?
|
| Immunohistochemistry | 15 | 2019 | 1603 | 0.390 |
Why?
|
| Genetic Predisposition to Disease | 9 | 2025 | 3250 | 0.390 |
Why?
|
| Mammary Neoplasms, Experimental | 5 | 2018 | 236 | 0.380 |
Why?
|
| Endometrial Neoplasms | 3 | 2020 | 107 | 0.380 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2012 | 9 | 0.380 |
Why?
|
| Ovary | 4 | 2015 | 356 | 0.370 |
Why?
|
| STAT3 Transcription Factor | 5 | 2019 | 215 | 0.370 |
Why?
|
| Neoplasm Staging | 9 | 2021 | 1293 | 0.370 |
Why?
|
| Genetic Heterogeneity | 1 | 2012 | 129 | 0.370 |
Why?
|
| X-linked Nuclear Protein | 2 | 2024 | 15 | 0.360 |
Why?
|
| src-Family Kinases | 3 | 2025 | 89 | 0.360 |
Why?
|
| Phosphoproteins | 4 | 2021 | 421 | 0.360 |
Why?
|
| Transcription Factor AP-1 | 3 | 2024 | 106 | 0.350 |
Why?
|
| Base Sequence | 12 | 2018 | 2773 | 0.350 |
Why?
|
| Astrocytes | 3 | 2021 | 259 | 0.350 |
Why?
|
| Rectal Neoplasms | 1 | 2012 | 77 | 0.350 |
Why?
|
| Survival Analysis | 9 | 2018 | 1474 | 0.350 |
Why?
|
| Blotting, Western | 14 | 2017 | 1019 | 0.350 |
Why?
|
| Repressor Proteins | 6 | 2018 | 765 | 0.340 |
Why?
|
| Laryngeal Neoplasms | 3 | 2016 | 85 | 0.340 |
Why?
|
| Neoplasm Grading | 6 | 2025 | 257 | 0.340 |
Why?
|
| RNA | 3 | 2024 | 526 | 0.330 |
Why?
|
| Kaplan-Meier Estimate | 12 | 2021 | 1025 | 0.330 |
Why?
|
| MAP Kinase Signaling System | 6 | 2024 | 299 | 0.330 |
Why?
|
| Cells, Cultured | 18 | 2019 | 2901 | 0.330 |
Why?
|
| Neoplasm Transplantation | 12 | 2021 | 360 | 0.330 |
Why?
|
| RNA, Small Interfering | 14 | 2018 | 655 | 0.320 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2021 | 144 | 0.320 |
Why?
|
| Collagen | 3 | 2016 | 294 | 0.320 |
Why?
|
| Nerve Tissue Proteins | 3 | 2023 | 1075 | 0.320 |
Why?
|
| Chromosome Aberrations | 4 | 2021 | 569 | 0.320 |
Why?
|
| Up-Regulation | 13 | 2021 | 828 | 0.320 |
Why?
|
| RNA Interference | 13 | 2017 | 495 | 0.310 |
Why?
|
| Genitalia, Female | 1 | 2010 | 46 | 0.310 |
Why?
|
| Vesicular Transport Proteins | 2 | 2021 | 120 | 0.310 |
Why?
|
| Bone Neoplasms | 4 | 2018 | 425 | 0.310 |
Why?
|
| Gene Expression | 12 | 2020 | 1489 | 0.310 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 3 | 2017 | 65 | 0.310 |
Why?
|
| Androgens | 5 | 2023 | 269 | 0.310 |
Why?
|
| Cancer-Associated Fibroblasts | 2 | 2021 | 20 | 0.310 |
Why?
|
| Survival Rate | 11 | 2021 | 2053 | 0.310 |
Why?
|
| Fibroblasts | 8 | 2016 | 824 | 0.310 |
Why?
|
| Mesoderm | 1 | 2009 | 104 | 0.300 |
Why?
|
| Heterografts | 10 | 2021 | 189 | 0.300 |
Why?
|
| Nuclear Receptor Coactivator 2 | 3 | 2014 | 144 | 0.300 |
Why?
|
| Nuclear Proteins | 5 | 2017 | 1211 | 0.300 |
Why?
|
| Extracellular Matrix | 4 | 2016 | 223 | 0.300 |
Why?
|
| Models, Biological | 10 | 2019 | 1374 | 0.300 |
Why?
|
| Telomerase | 4 | 2024 | 153 | 0.300 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 2 | 2022 | 41 | 0.290 |
Why?
|
| Oncogene Proteins | 3 | 2018 | 133 | 0.290 |
Why?
|
| Breast | 4 | 2022 | 209 | 0.290 |
Why?
|
| Neoplasm, Residual | 1 | 2009 | 132 | 0.290 |
Why?
|
| ras Proteins | 4 | 2015 | 140 | 0.290 |
Why?
|
| Chromatin | 4 | 2019 | 488 | 0.290 |
Why?
|
| Transfection | 10 | 2018 | 949 | 0.290 |
Why?
|
| Infertility, Female | 4 | 2021 | 144 | 0.290 |
Why?
|
| Leiomyosarcoma | 3 | 2013 | 25 | 0.280 |
Why?
|
| Cell Line | 7 | 2023 | 2568 | 0.280 |
Why?
|
| Macrophages | 5 | 2022 | 644 | 0.280 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 3 | 2020 | 79 | 0.280 |
Why?
|
| Cell Cycle | 9 | 2020 | 584 | 0.280 |
Why?
|
| Oxidative Phosphorylation | 3 | 2024 | 126 | 0.280 |
Why?
|
| Middle Aged | 31 | 2025 | 27337 | 0.280 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 2 | 2020 | 77 | 0.280 |
Why?
|
| Epigenomics | 3 | 2025 | 175 | 0.270 |
Why?
|
| Gene Dosage | 5 | 2020 | 440 | 0.270 |
Why?
|
| Homeostasis | 4 | 2023 | 685 | 0.270 |
Why?
|
| Gene Amplification | 2 | 2021 | 227 | 0.270 |
Why?
|
| Databases, Nucleic Acid | 2 | 2008 | 74 | 0.260 |
Why?
|
| Genome | 3 | 2022 | 490 | 0.260 |
Why?
|
| DNA-Binding Proteins | 6 | 2017 | 1879 | 0.260 |
Why?
|
| Metabolomics | 5 | 2024 | 456 | 0.260 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 2 | 2021 | 88 | 0.260 |
Why?
|
| Antigens, Ly | 2 | 2020 | 32 | 0.260 |
Why?
|
| Inflammation | 7 | 2024 | 1431 | 0.260 |
Why?
|
| Urologic Neoplasms | 2 | 2017 | 37 | 0.260 |
Why?
|
| Nitriles | 4 | 2021 | 141 | 0.250 |
Why?
|
| Epithelium | 7 | 2023 | 339 | 0.250 |
Why?
|
| Carrier Proteins | 3 | 2023 | 1011 | 0.250 |
Why?
|
| beta Catenin | 7 | 2020 | 204 | 0.250 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2021 | 2743 | 0.240 |
Why?
|
| Frizzled Receptors | 1 | 2025 | 20 | 0.240 |
Why?
|
| Adenoma, Oxyphilic | 1 | 2025 | 12 | 0.240 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2018 | 103 | 0.240 |
Why?
|
| Genetic Testing | 1 | 2012 | 1059 | 0.240 |
Why?
|
| N-Myc Proto-Oncogene Protein | 2 | 2024 | 56 | 0.240 |
Why?
|
| Kruppel-Like Transcription Factors | 3 | 2015 | 111 | 0.240 |
Why?
|
| Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase | 2 | 2015 | 6 | 0.240 |
Why?
|
| Phosphorylation | 8 | 2018 | 1540 | 0.230 |
Why?
|
| Child | 8 | 2025 | 25070 | 0.230 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2025 | 39 | 0.230 |
Why?
|
| High-Throughput Nucleotide Sequencing | 5 | 2020 | 910 | 0.230 |
Why?
|
| Histone-Lysine N-Methyltransferase | 3 | 2020 | 154 | 0.230 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2018 | 188 | 0.230 |
Why?
|
| Collagen Type I | 3 | 2022 | 114 | 0.230 |
Why?
|
| Mice, Inbred C57BL | 15 | 2024 | 4505 | 0.230 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 12 | 2 | 2018 | 18 | 0.230 |
Why?
|
| Biguanides | 1 | 2025 | 12 | 0.230 |
Why?
|
| Head and Neck Neoplasms | 3 | 2023 | 587 | 0.230 |
Why?
|
| Gene Silencing | 5 | 2018 | 224 | 0.230 |
Why?
|
| Algorithms | 6 | 2018 | 1635 | 0.230 |
Why?
|
| Interleukin-8 | 2 | 2016 | 203 | 0.230 |
Why?
|
| Proportional Hazards Models | 7 | 2017 | 1343 | 0.230 |
Why?
|
| Mammary Tumor Virus, Mouse | 2 | 2018 | 98 | 0.230 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2018 | 118 | 0.220 |
Why?
|
| Cell Survival | 9 | 2024 | 834 | 0.220 |
Why?
|
| Phenotype | 9 | 2018 | 4305 | 0.220 |
Why?
|
| Plasma Cells | 1 | 2025 | 53 | 0.220 |
Why?
|
| SOXB1 Transcription Factors | 2 | 2015 | 57 | 0.220 |
Why?
|
| Macrophage Migration-Inhibitory Factors | 1 | 2024 | 15 | 0.220 |
Why?
|
| Glutaminase | 1 | 2024 | 17 | 0.220 |
Why?
|
| Decidua | 6 | 2015 | 135 | 0.220 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2024 | 45 | 0.220 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2017 | 560 | 0.210 |
Why?
|
| Gene Fusion | 3 | 2022 | 59 | 0.210 |
Why?
|
| Genes, Essential | 1 | 2024 | 42 | 0.210 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 4 | 2017 | 281 | 0.210 |
Why?
|
| Disease-Free Survival | 7 | 2020 | 902 | 0.210 |
Why?
|
| Aged | 21 | 2025 | 20039 | 0.210 |
Why?
|
| Mice, Inbred NOD | 7 | 2021 | 287 | 0.210 |
Why?
|
| Cell Adhesion | 6 | 2022 | 298 | 0.210 |
Why?
|
| Promoter Regions, Genetic | 11 | 2017 | 1211 | 0.210 |
Why?
|
| Morphogenesis | 2 | 2016 | 190 | 0.210 |
Why?
|
| Tissue Array Analysis | 8 | 2021 | 135 | 0.210 |
Why?
|
| Tumor Suppressor Proteins | 5 | 2019 | 473 | 0.210 |
Why?
|
| A549 Cells | 2 | 2021 | 48 | 0.210 |
Why?
|
| Actin Cytoskeleton | 2 | 2015 | 48 | 0.210 |
Why?
|
| Carcinoma, Papillary | 2 | 2015 | 90 | 0.210 |
Why?
|
| Intestinal Neoplasms | 1 | 2024 | 37 | 0.210 |
Why?
|
| Aminopyridines | 1 | 2024 | 51 | 0.210 |
Why?
|
| Smad4 Protein | 4 | 2018 | 55 | 0.200 |
Why?
|
| Phenylthiohydantoin | 2 | 2021 | 14 | 0.200 |
Why?
|
| Proteasome Endopeptidase Complex | 3 | 2014 | 232 | 0.200 |
Why?
|
| Glutamine | 1 | 2024 | 196 | 0.200 |
Why?
|
| Predictive Value of Tests | 4 | 2018 | 2173 | 0.200 |
Why?
|
| Abortion, Spontaneous | 2 | 2014 | 82 | 0.200 |
Why?
|
| Lung | 4 | 2025 | 1509 | 0.200 |
Why?
|
| Fibroblast Growth Factors | 2 | 2015 | 162 | 0.200 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2016 | 198 | 0.200 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2014 | 426 | 0.200 |
Why?
|
| Smad Proteins | 1 | 2023 | 42 | 0.200 |
Why?
|
| Viral Load | 1 | 2025 | 400 | 0.200 |
Why?
|
| Endocytosis | 2 | 2021 | 122 | 0.190 |
Why?
|
| Exome | 5 | 2015 | 1065 | 0.190 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2024 | 572 | 0.190 |
Why?
|
| Benzamides | 2 | 2021 | 118 | 0.190 |
Why?
|
| Nerve Sheath Neoplasms | 2 | 2013 | 18 | 0.190 |
Why?
|
| Information Storage and Retrieval | 1 | 2003 | 62 | 0.190 |
Why?
|
| Pyrroles | 1 | 2024 | 176 | 0.190 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 4 | 2017 | 1306 | 0.190 |
Why?
|
| Carcinoma, Pancreatic Ductal | 1 | 2024 | 163 | 0.190 |
Why?
|
| Mutation Rate | 2 | 2012 | 67 | 0.190 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2003 | 126 | 0.190 |
Why?
|
| DNA Repair | 4 | 2025 | 552 | 0.190 |
Why?
|
| Cohort Studies | 6 | 2025 | 4892 | 0.190 |
Why?
|
| Gene Regulatory Networks | 3 | 2014 | 363 | 0.190 |
Why?
|
| STAT5 Transcription Factor | 1 | 2022 | 85 | 0.190 |
Why?
|
| Smad2 Protein | 2 | 2019 | 49 | 0.190 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2019 | 235 | 0.190 |
Why?
|
| Janus Kinase 2 | 2 | 2015 | 131 | 0.190 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2022 | 16 | 0.190 |
Why?
|
| Smad3 Protein | 2 | 2019 | 52 | 0.180 |
Why?
|
| Antigens, Neoplasm | 1 | 2025 | 412 | 0.180 |
Why?
|
| Creatine Kinase, BB Form | 1 | 2021 | 5 | 0.180 |
Why?
|
| rho GTP-Binding Proteins | 3 | 2017 | 68 | 0.180 |
Why?
|
| Polymerase Chain Reaction | 5 | 2015 | 1490 | 0.180 |
Why?
|
| Cell Respiration | 2 | 2019 | 22 | 0.180 |
Why?
|
| Real-Time Polymerase Chain Reaction | 8 | 2017 | 522 | 0.180 |
Why?
|
| Cluster Analysis | 4 | 2013 | 409 | 0.180 |
Why?
|
| raf Kinases | 2 | 2015 | 5 | 0.180 |
Why?
|
| Serine Endopeptidases | 3 | 2017 | 182 | 0.180 |
Why?
|
| Endosomes | 1 | 2021 | 62 | 0.180 |
Why?
|
| Genetic Variation | 2 | 2018 | 1520 | 0.180 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2021 | 25 | 0.180 |
Why?
|
| AMP-Activated Protein Kinases | 3 | 2025 | 168 | 0.180 |
Why?
|
| Adolescent | 8 | 2025 | 19942 | 0.180 |
Why?
|
| Oncogene Protein v-akt | 2 | 2020 | 33 | 0.180 |
Why?
|
| B7-H1 Antigen | 2 | 2023 | 125 | 0.180 |
Why?
|
| Pediatrics | 2 | 2021 | 1205 | 0.170 |
Why?
|
| Mutant Proteins | 2 | 2019 | 112 | 0.170 |
Why?
|
| Terminology as Topic | 1 | 2003 | 221 | 0.170 |
Why?
|
| Gene Deletion | 5 | 2017 | 768 | 0.170 |
Why?
|
| Phosphotransferases | 1 | 2021 | 34 | 0.170 |
Why?
|
| Glucosyltransferases | 1 | 2021 | 41 | 0.170 |
Why?
|
| Cadherins | 2 | 2019 | 174 | 0.170 |
Why?
|
| Adult | 23 | 2025 | 30262 | 0.170 |
Why?
|
| Aurora Kinase A | 3 | 2016 | 35 | 0.170 |
Why?
|
| Gene Editing | 1 | 2023 | 197 | 0.170 |
Why?
|
| HEK293 Cells | 6 | 2021 | 768 | 0.170 |
Why?
|
| Neuropeptide Y | 1 | 2020 | 34 | 0.170 |
Why?
|
| DNA Replication | 2 | 2020 | 342 | 0.170 |
Why?
|
| Neurons | 3 | 2021 | 1908 | 0.170 |
Why?
|
| Spermine Synthase | 1 | 2020 | 2 | 0.170 |
Why?
|
| Spermine | 1 | 2020 | 5 | 0.170 |
Why?
|
| Caveolin 1 | 1 | 2020 | 51 | 0.170 |
Why?
|
| Microfilament Proteins | 3 | 2017 | 264 | 0.170 |
Why?
|
| DNA, Neoplasm | 4 | 2020 | 287 | 0.170 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2021 | 123 | 0.170 |
Why?
|
| Bronchi | 1 | 2021 | 102 | 0.160 |
Why?
|
| Intestines | 1 | 2024 | 580 | 0.160 |
Why?
|
| Sphingolipids | 1 | 2020 | 33 | 0.160 |
Why?
|
| Carcinoma, Medullary | 1 | 2020 | 15 | 0.160 |
Why?
|
| Protein Binding | 8 | 2019 | 1672 | 0.160 |
Why?
|
| SMARCB1 Protein | 1 | 2020 | 32 | 0.160 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2020 | 271 | 0.160 |
Why?
|
| Forkhead Box Protein O1 | 2 | 2017 | 96 | 0.160 |
Why?
|
| Quinazolines | 5 | 2016 | 178 | 0.160 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2020 | 96 | 0.160 |
Why?
|
| Glucose | 1 | 2024 | 845 | 0.160 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2019 | 14 | 0.160 |
Why?
|
| Myocardium | 2 | 2015 | 835 | 0.160 |
Why?
|
| Genome, Mitochondrial | 1 | 2020 | 31 | 0.160 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2016 | 348 | 0.160 |
Why?
|
| Osteosarcoma | 2 | 2015 | 258 | 0.160 |
Why?
|
| Cell Growth Processes | 4 | 2014 | 60 | 0.160 |
Why?
|
| Obesity | 1 | 2011 | 2326 | 0.160 |
Why?
|
| Translocation, Genetic | 1 | 2021 | 348 | 0.160 |
Why?
|
| Peritoneal Neoplasms | 1 | 2020 | 53 | 0.150 |
Why?
|
| Child, Preschool | 2 | 2025 | 14350 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2019 | 21 | 0.150 |
Why?
|
| GTPase-Activating Proteins | 1 | 2019 | 85 | 0.150 |
Why?
|
| Ki-67 Antigen | 2 | 2017 | 102 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 2019 | 15 | 0.150 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2020 | 147 | 0.150 |
Why?
|
| Wnt-5a Protein | 1 | 2019 | 23 | 0.150 |
Why?
|
| Estrogen Receptor beta | 1 | 2019 | 81 | 0.150 |
Why?
|
| Receptor, Notch1 | 2 | 2016 | 73 | 0.150 |
Why?
|
| Cell Culture Techniques | 3 | 2021 | 269 | 0.150 |
Why?
|
| Botulinum Toxins, Type A | 2 | 2020 | 157 | 0.150 |
Why?
|
| Nucleic Acid Conformation | 2 | 2010 | 173 | 0.150 |
Why?
|
| Mice, Inbred BALB C | 7 | 2018 | 1001 | 0.150 |
Why?
|
| Leiomyoma | 2 | 2017 | 73 | 0.150 |
Why?
|
| DNA, Mitochondrial | 3 | 2020 | 232 | 0.150 |
Why?
|
| Fatty Acids | 2 | 2025 | 350 | 0.150 |
Why?
|
| Pyrimidines | 4 | 2017 | 393 | 0.150 |
Why?
|
| Cell Communication | 3 | 2021 | 181 | 0.150 |
Why?
|
| Pregnancy | 10 | 2021 | 7391 | 0.150 |
Why?
|
| Esthesioneuroblastoma, Olfactory | 1 | 2018 | 3 | 0.150 |
Why?
|
| Adaptive Immunity | 1 | 2019 | 99 | 0.150 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2020 | 963 | 0.150 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2017 | 150 | 0.150 |
Why?
|
| GATA Transcription Factors | 1 | 2018 | 7 | 0.150 |
Why?
|
| Cell Self Renewal | 1 | 2018 | 47 | 0.150 |
Why?
|
| Nose Neoplasms | 1 | 2018 | 29 | 0.140 |
Why?
|
| Inflammatory Breast Neoplasms | 1 | 2018 | 6 | 0.140 |
Why?
|
| Cell Polarity | 2 | 2021 | 116 | 0.140 |
Why?
|
| Genes, ras | 4 | 2015 | 100 | 0.140 |
Why?
|
| Clinical Decision-Making | 2 | 2018 | 297 | 0.140 |
Why?
|
| Cathepsins | 1 | 2018 | 25 | 0.140 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2020 | 105 | 0.140 |
Why?
|
| Cytokines | 4 | 2013 | 1316 | 0.140 |
Why?
|
| Spiro Compounds | 2 | 2015 | 10 | 0.140 |
Why?
|
| Nasal Cavity | 1 | 2018 | 52 | 0.140 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2014 | 974 | 0.140 |
Why?
|
| Estrogens | 4 | 2021 | 423 | 0.140 |
Why?
|
| Wnt1 Protein | 3 | 2018 | 74 | 0.140 |
Why?
|
| Virus Replication | 1 | 2021 | 593 | 0.140 |
Why?
|
| Recurrence | 1 | 2021 | 1408 | 0.140 |
Why?
|
| Mutation, Missense | 2 | 2015 | 888 | 0.140 |
Why?
|
| Infertility | 1 | 2019 | 77 | 0.140 |
Why?
|
| Proteoglycans | 1 | 2018 | 83 | 0.140 |
Why?
|
| I-kappa B Kinase | 1 | 2017 | 56 | 0.140 |
Why?
|
| Internet | 1 | 2021 | 397 | 0.140 |
Why?
|
| Denervation | 1 | 2017 | 26 | 0.140 |
Why?
|
| Mice, Inbred Strains | 2 | 2015 | 291 | 0.140 |
Why?
|
| Immunomodulation | 1 | 2018 | 76 | 0.140 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2015 | 99 | 0.140 |
Why?
|
| Transcriptional Activation | 4 | 2020 | 415 | 0.140 |
Why?
|
| Thy-1 Antigens | 1 | 2017 | 20 | 0.140 |
Why?
|
| Sirolimus | 3 | 2014 | 224 | 0.140 |
Why?
|
| Cell Division | 2 | 2013 | 722 | 0.130 |
Why?
|
| Neoplastic Cells, Circulating | 2 | 2015 | 76 | 0.130 |
Why?
|
| NFI Transcription Factors | 1 | 2017 | 50 | 0.130 |
Why?
|
| Interleukin-17 | 1 | 2018 | 124 | 0.130 |
Why?
|
| Prostatic Hyperplasia | 2 | 2016 | 114 | 0.130 |
Why?
|
| Dishevelled Proteins | 1 | 2017 | 43 | 0.130 |
Why?
|
| Oncogene Fusion | 1 | 2017 | 24 | 0.130 |
Why?
|
| HMGB Proteins | 1 | 2017 | 9 | 0.130 |
Why?
|
| Liver Neoplasms | 2 | 2020 | 1347 | 0.130 |
Why?
|
| Transplantation, Heterologous | 6 | 2014 | 250 | 0.130 |
Why?
|
| RGS Proteins | 1 | 2017 | 47 | 0.130 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2017 | 75 | 0.130 |
Why?
|
| Enzyme Activation | 3 | 2021 | 582 | 0.130 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2018 | 112 | 0.130 |
Why?
|
| Spinal Cord Regeneration | 1 | 2016 | 4 | 0.130 |
Why?
|
| rho-Associated Kinases | 1 | 2017 | 47 | 0.130 |
Why?
|
| Datasets as Topic | 1 | 2017 | 102 | 0.130 |
Why?
|
| Osteoblasts | 1 | 2018 | 160 | 0.130 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2018 | 133 | 0.130 |
Why?
|
| High-Throughput Screening Assays | 2 | 2018 | 114 | 0.130 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 2016 | 10 | 0.130 |
Why?
|
| Spindle Apparatus | 2 | 2014 | 44 | 0.130 |
Why?
|
| Bone Morphogenetic Protein 2 | 2 | 2014 | 87 | 0.130 |
Why?
|
| DNA | 3 | 2024 | 1430 | 0.130 |
Why?
|
| Retroviridae | 1 | 2017 | 181 | 0.130 |
Why?
|
| Exosomes | 1 | 2017 | 57 | 0.130 |
Why?
|
| Nuclear Receptor Coactivator 3 | 2 | 2016 | 253 | 0.130 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2016 | 42 | 0.130 |
Why?
|
| Statistics, Nonparametric | 3 | 2012 | 418 | 0.130 |
Why?
|
| Forkhead Box Protein M1 | 1 | 2016 | 6 | 0.130 |
Why?
|
| Aromatase Inhibitors | 1 | 2017 | 78 | 0.130 |
Why?
|
| Monocytes | 2 | 2016 | 329 | 0.120 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2018 | 121 | 0.120 |
Why?
|
| Glioblastoma | 1 | 2020 | 330 | 0.120 |
Why?
|
| Polycomb Repressive Complex 2 | 2 | 2014 | 27 | 0.120 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2016 | 92 | 0.120 |
Why?
|
| Coculture Techniques | 5 | 2017 | 229 | 0.120 |
Why?
|
| Pyrazoles | 3 | 2017 | 313 | 0.120 |
Why?
|
| Lymphocytes | 1 | 2018 | 354 | 0.120 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2016 | 37 | 0.120 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2016 | 24 | 0.120 |
Why?
|
| Primary Myelofibrosis | 1 | 2016 | 50 | 0.120 |
Why?
|
| Integrin beta1 | 1 | 2016 | 53 | 0.120 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2015 | 31 | 0.120 |
Why?
|
| Receptors, Cell Surface | 1 | 2018 | 423 | 0.120 |
Why?
|
| Receptor, IGF Type 1 | 3 | 2011 | 92 | 0.120 |
Why?
|
| Adoptive Transfer | 2 | 2014 | 231 | 0.120 |
Why?
|
| RNA Splicing Factors | 1 | 2016 | 53 | 0.120 |
Why?
|
| Mixed Function Oxygenases | 1 | 2016 | 36 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2015 | 25 | 0.120 |
Why?
|
| Duodenal Neoplasms | 1 | 2016 | 27 | 0.120 |
Why?
|
| Mice, 129 Strain | 5 | 2015 | 96 | 0.120 |
Why?
|
| Precancerous Conditions | 1 | 2018 | 276 | 0.120 |
Why?
|
| Retinoblastoma Protein | 2 | 2013 | 78 | 0.120 |
Why?
|
| E2F1 Transcription Factor | 1 | 2016 | 48 | 0.120 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2015 | 22 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2016 | 57 | 0.120 |
Why?
|
| Centrioles | 1 | 2015 | 5 | 0.120 |
Why?
|
| Tongue Neoplasms | 1 | 2015 | 30 | 0.120 |
Why?
|
| Neutrophils | 1 | 2018 | 351 | 0.120 |
Why?
|
| Inhibitor of Apoptosis Proteins | 2 | 2013 | 43 | 0.120 |
Why?
|
| Neuroglia | 1 | 2017 | 206 | 0.120 |
Why?
|
| GATA3 Transcription Factor | 2 | 2012 | 41 | 0.120 |
Why?
|
| Oxidative Stress | 3 | 2015 | 752 | 0.120 |
Why?
|
| Dioxygenases | 1 | 2016 | 65 | 0.120 |
Why?
|
| Mitochondria, Heart | 1 | 2015 | 49 | 0.120 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2015 | 16 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2015 | 79 | 0.120 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2017 | 217 | 0.110 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2013 | 86 | 0.110 |
Why?
|
| T-Lymphocytes | 2 | 2014 | 1704 | 0.110 |
Why?
|
| Biopsy | 3 | 2021 | 1219 | 0.110 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2015 | 80 | 0.110 |
Why?
|
| Fallopian Tubes | 2 | 2014 | 73 | 0.110 |
Why?
|
| Transcription Factor RelA | 1 | 2015 | 50 | 0.110 |
Why?
|
| Saliva | 1 | 2015 | 128 | 0.110 |
Why?
|
| Molecular Sequence Data | 7 | 2016 | 3600 | 0.110 |
Why?
|
| Melanoma | 3 | 2013 | 927 | 0.110 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2015 | 31 | 0.110 |
Why?
|
| Immunotherapy | 1 | 2020 | 738 | 0.110 |
Why?
|
| Pyridones | 2 | 2013 | 124 | 0.110 |
Why?
|
| Energy Metabolism | 2 | 2017 | 761 | 0.110 |
Why?
|
| Inhibitor of Differentiation Proteins | 2 | 2011 | 11 | 0.110 |
Why?
|
| 3' Untranslated Regions | 2 | 2012 | 155 | 0.110 |
Why?
|
| Imidazoles | 2 | 2015 | 212 | 0.110 |
Why?
|
| Aged, 80 and over | 8 | 2020 | 6579 | 0.110 |
Why?
|
| Conserved Sequence | 2 | 2012 | 286 | 0.110 |
Why?
|
| Dwarfism | 1 | 2015 | 102 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2014 | 65 | 0.110 |
Why?
|
| Ribonucleoside Diphosphate Reductase | 1 | 2014 | 12 | 0.110 |
Why?
|
| Indoles | 1 | 2015 | 197 | 0.110 |
Why?
|
| MCF-7 Cells | 4 | 2016 | 207 | 0.110 |
Why?
|
| Dioxolanes | 1 | 2014 | 11 | 0.110 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2014 | 353 | 0.110 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase Catalytic Subunits | 1 | 2014 | 3 | 0.110 |
Why?
|
| GTP Phosphohydrolases | 1 | 2015 | 156 | 0.110 |
Why?
|
| Drug Repositioning | 1 | 2014 | 27 | 0.110 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 3 | 2024 | 149 | 0.110 |
Why?
|
| MAP Kinase Kinase Kinase 3 | 1 | 2014 | 9 | 0.110 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 2 | 2013 | 37 | 0.110 |
Why?
|
| beta Karyopherins | 1 | 2014 | 14 | 0.110 |
Why?
|
| Guidelines as Topic | 1 | 2015 | 188 | 0.110 |
Why?
|
| Interleukin-7 | 1 | 2014 | 45 | 0.110 |
Why?
|
| Virus Integration | 1 | 2014 | 37 | 0.110 |
Why?
|
| Urogenital Abnormalities | 1 | 2016 | 160 | 0.110 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2013 | 30 | 0.110 |
Why?
|
| MEF2 Transcription Factors | 1 | 2014 | 34 | 0.110 |
Why?
|
| DNA, Complementary | 3 | 2010 | 435 | 0.100 |
Why?
|
| Phosphofructokinase-2 | 1 | 2013 | 22 | 0.100 |
Why?
|
| Adult Stem Cells | 1 | 2014 | 52 | 0.100 |
Why?
|
| Aspergillus niger | 1 | 2013 | 16 | 0.100 |
Why?
|
| Neurilemmoma | 1 | 2014 | 40 | 0.100 |
Why?
|
| GRB10 Adaptor Protein | 1 | 2013 | 6 | 0.100 |
Why?
|
| Activin Receptors, Type I | 1 | 2013 | 33 | 0.100 |
Why?
|
| Mammary Glands, Human | 2 | 2013 | 80 | 0.100 |
Why?
|
| Chordoma | 1 | 2013 | 16 | 0.100 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2013 | 17 | 0.100 |
Why?
|
| Interleukin-15 | 1 | 2014 | 90 | 0.100 |
Why?
|
| Autoantigens | 1 | 2014 | 103 | 0.100 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2013 | 43 | 0.100 |
Why?
|
| Spinal Cord Injuries | 1 | 2016 | 275 | 0.100 |
Why?
|
| Hyaluronan Receptors | 2 | 2013 | 64 | 0.100 |
Why?
|
| Microarray Analysis | 4 | 2015 | 224 | 0.100 |
Why?
|
| Skull Base Neoplasms | 1 | 2013 | 31 | 0.100 |
Why?
|
| Quantitative Trait Loci | 1 | 2015 | 295 | 0.100 |
Why?
|
| In Vitro Techniques | 3 | 2021 | 821 | 0.100 |
Why?
|
| Synapses | 1 | 2017 | 430 | 0.100 |
Why?
|
| Citric Acid Cycle | 1 | 2013 | 42 | 0.100 |
Why?
|
| Case-Control Studies | 6 | 2017 | 3297 | 0.100 |
Why?
|
| Autocrine Communication | 1 | 2013 | 28 | 0.100 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2013 | 51 | 0.100 |
Why?
|
| Treatment Outcome | 7 | 2020 | 12352 | 0.100 |
Why?
|
| Endoribonucleases | 2 | 2010 | 82 | 0.100 |
Why?
|
| Antigens, CD19 | 1 | 2014 | 170 | 0.100 |
Why?
|
| Integrases | 3 | 2018 | 151 | 0.100 |
Why?
|
| Chemokine CXCL12 | 1 | 2013 | 34 | 0.100 |
Why?
|
| Sarcoma | 1 | 2015 | 205 | 0.100 |
Why?
|
| Carcinoma, Basal Cell | 1 | 2013 | 66 | 0.100 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2012 | 15 | 0.100 |
Why?
|
| Myotonic Dystrophy | 1 | 2014 | 119 | 0.100 |
Why?
|
| Genes, p16 | 1 | 2012 | 11 | 0.100 |
Why?
|
| Immunologic Memory | 1 | 2014 | 194 | 0.100 |
Why?
|
| Fibrinogen | 1 | 2013 | 154 | 0.100 |
Why?
|
| Genes, erbB-2 | 1 | 2012 | 32 | 0.100 |
Why?
|
| Retinoblastoma-Binding Protein 7 | 1 | 2012 | 6 | 0.100 |
Why?
|
| Primary Cell Culture | 3 | 2020 | 103 | 0.100 |
Why?
|
| Tissue Distribution | 2 | 2010 | 364 | 0.100 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2013 | 138 | 0.100 |
Why?
|
| Peptide Hydrolases | 1 | 2013 | 132 | 0.100 |
Why?
|
| Receptors, CXCR4 | 1 | 2013 | 65 | 0.100 |
Why?
|
| Mucin-4 | 1 | 2012 | 11 | 0.100 |
Why?
|
| M Phase Cell Cycle Checkpoints | 1 | 2012 | 5 | 0.100 |
Why?
|
| Genes, BRCA1 | 1 | 2012 | 60 | 0.090 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2012 | 17 | 0.090 |
Why?
|
| Leukemia, Myeloid, Chronic-Phase | 1 | 2012 | 11 | 0.090 |
Why?
|
| Secretory Vesicles | 2 | 2023 | 20 | 0.090 |
Why?
|
| Calcium-Binding Proteins | 2 | 2015 | 324 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 376 | 0.090 |
Why?
|
| Naphthoquinones | 1 | 2012 | 8 | 0.090 |
Why?
|
| Mitosis | 2 | 2011 | 191 | 0.090 |
Why?
|
| Casein Kinase I | 1 | 2012 | 11 | 0.090 |
Why?
|
| Reproducibility of Results | 5 | 2018 | 2865 | 0.090 |
Why?
|
| Immunoenzyme Techniques | 4 | 2013 | 243 | 0.090 |
Why?
|
| Fertility | 1 | 2014 | 250 | 0.090 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2011 | 21 | 0.090 |
Why?
|
| Metabolome | 4 | 2020 | 318 | 0.090 |
Why?
|
| Brain | 2 | 2021 | 3021 | 0.090 |
Why?
|
| Immunoblotting | 4 | 2015 | 291 | 0.090 |
Why?
|
| Thiazoles | 1 | 2012 | 97 | 0.090 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2011 | 36 | 0.090 |
Why?
|
| Genes, myc | 1 | 2011 | 94 | 0.090 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2014 | 361 | 0.090 |
Why?
|
| Proteolysis | 3 | 2018 | 177 | 0.090 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2012 | 101 | 0.090 |
Why?
|
| Finches | 1 | 2011 | 6 | 0.090 |
Why?
|
| RNA Splicing | 1 | 2012 | 231 | 0.090 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 4 | 1 | 2011 | 14 | 0.090 |
Why?
|
| Keratin-6 | 1 | 2011 | 13 | 0.090 |
Why?
|
| Serum Response Factor | 1 | 2011 | 28 | 0.090 |
Why?
|
| Trans-Activators | 2 | 2015 | 672 | 0.090 |
Why?
|
| Purine-Nucleoside Phosphorylase | 1 | 2011 | 9 | 0.090 |
Why?
|
| Prosencephalon | 1 | 2011 | 36 | 0.090 |
Why?
|
| Vocalization, Animal | 1 | 2011 | 25 | 0.090 |
Why?
|
| Auditory Cortex | 1 | 2011 | 21 | 0.090 |
Why?
|
| PPAR gamma | 1 | 2011 | 86 | 0.090 |
Why?
|
| Chromatin Immunoprecipitation | 4 | 2014 | 230 | 0.090 |
Why?
|
| Cellular Senescence | 4 | 2015 | 181 | 0.090 |
Why?
|
| Neovascularization, Pathologic | 2 | 2021 | 239 | 0.090 |
Why?
|
| Lymphoma | 1 | 2014 | 315 | 0.090 |
Why?
|
| Triazines | 1 | 2010 | 31 | 0.090 |
Why?
|
| Protein Biosynthesis | 2 | 2010 | 565 | 0.080 |
Why?
|
| Eukaryotic Initiation Factor-3 | 1 | 2010 | 10 | 0.080 |
Why?
|
| Cell Nucleus | 1 | 2013 | 558 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2010 | 39 | 0.080 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 135 | 0.080 |
Why?
|
| Boston | 1 | 2010 | 112 | 0.080 |
Why?
|
| Myocytes, Cardiac | 1 | 2015 | 609 | 0.080 |
Why?
|
| Cell Dedifferentiation | 1 | 2010 | 20 | 0.080 |
Why?
|
| Claudins | 1 | 2010 | 30 | 0.080 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 3 | 2019 | 65 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2020 | 413 | 0.080 |
Why?
|
| Age Factors | 3 | 2020 | 2762 | 0.080 |
Why?
|
| Antigens, Differentiation | 1 | 2010 | 62 | 0.080 |
Why?
|
| Interleukin-13 | 1 | 2010 | 94 | 0.080 |
Why?
|
| Neoplasms, Plasma Cell | 1 | 2009 | 3 | 0.080 |
Why?
|
| Lymphoma, Large-Cell, Immunoblastic | 1 | 2009 | 5 | 0.080 |
Why?
|
| Reference Values | 1 | 2011 | 678 | 0.080 |
Why?
|
| Myeloproliferative Disorders | 1 | 2011 | 86 | 0.080 |
Why?
|
| Binding Sites | 4 | 2016 | 1193 | 0.080 |
Why?
|
| Nuclear Matrix-Associated Proteins | 1 | 2009 | 19 | 0.080 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2009 | 19 | 0.080 |
Why?
|
| AC133 Antigen | 3 | 2016 | 35 | 0.080 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2011 | 128 | 0.080 |
Why?
|
| Claudin-1 | 1 | 2009 | 19 | 0.080 |
Why?
|
| Bone Marrow Cells | 1 | 2011 | 236 | 0.080 |
Why?
|
| CD24 Antigen | 1 | 2009 | 30 | 0.080 |
Why?
|
| Extracellular Space | 1 | 2009 | 83 | 0.080 |
Why?
|
| Tumor Burden | 3 | 2017 | 228 | 0.080 |
Why?
|
| Genetic Techniques | 1 | 2010 | 99 | 0.080 |
Why?
|
| Time Factors | 4 | 2017 | 6025 | 0.080 |
Why?
|
| Young Adult | 7 | 2020 | 9596 | 0.080 |
Why?
|
| Congresses as Topic | 1 | 2010 | 174 | 0.080 |
Why?
|
| Cornea | 1 | 2014 | 590 | 0.080 |
Why?
|
| Pregnancy Complications | 1 | 2014 | 537 | 0.080 |
Why?
|
| Mice, Mutant Strains | 3 | 2017 | 363 | 0.080 |
Why?
|
| Focal Adhesions | 2 | 2021 | 14 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2020 | 781 | 0.080 |
Why?
|
| Evolution, Molecular | 1 | 2012 | 686 | 0.080 |
Why?
|
| Chromatography, Liquid | 3 | 2020 | 231 | 0.070 |
Why?
|
| Genes | 2 | 2011 | 305 | 0.070 |
Why?
|
| Amino Acids | 1 | 2011 | 614 | 0.070 |
Why?
|
| Prospective Studies | 3 | 2020 | 6167 | 0.070 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2014 | 555 | 0.070 |
Why?
|
| Biomarkers | 5 | 2018 | 3143 | 0.070 |
Why?
|
| Ovariectomy | 1 | 2008 | 166 | 0.070 |
Why?
|
| Reactive Oxygen Species | 3 | 2016 | 489 | 0.070 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2009 | 561 | 0.070 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2020 | 276 | 0.070 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2009 | 148 | 0.070 |
Why?
|
| rhoA GTP-Binding Protein | 2 | 2018 | 44 | 0.070 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2007 | 57 | 0.070 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2018 | 130 | 0.070 |
Why?
|
| Sex Factors | 3 | 2020 | 1292 | 0.070 |
Why?
|
| Flow Cytometry | 3 | 2017 | 757 | 0.070 |
Why?
|
| Radiation Tolerance | 2 | 2020 | 58 | 0.070 |
Why?
|
| HCT116 Cells | 2 | 2019 | 59 | 0.070 |
Why?
|
| Embryonic Stem Cells | 1 | 2008 | 162 | 0.070 |
Why?
|
| Cell Membrane | 1 | 2009 | 447 | 0.070 |
Why?
|
| Sequence Alignment | 2 | 2011 | 584 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2025 | 1820 | 0.060 |
Why?
|
| Oxidation-Reduction | 2 | 2019 | 420 | 0.060 |
Why?
|
| Aldehyde Dehydrogenase | 2 | 2017 | 41 | 0.060 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2006 | 48 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2017 | 299 | 0.060 |
Why?
|
| Diseases in Twins | 1 | 2006 | 92 | 0.060 |
Why?
|
| Ligands | 3 | 2013 | 478 | 0.060 |
Why?
|
| Twins, Monozygotic | 1 | 2006 | 125 | 0.060 |
Why?
|
| Biopsy, Needle | 2 | 2017 | 215 | 0.060 |
Why?
|
| Receptor, ErbB-3 | 2 | 2016 | 16 | 0.060 |
Why?
|
| Amino Acid Sequence | 4 | 2014 | 2550 | 0.060 |
Why?
|
| NF-kappa B | 2 | 2020 | 438 | 0.060 |
Why?
|
| Co-Repressor Proteins | 2 | 2019 | 37 | 0.060 |
Why?
|
| Mitotic Index | 2 | 2017 | 17 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 2 | 2020 | 309 | 0.060 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2017 | 115 | 0.060 |
Why?
|
| Dasatinib | 1 | 2025 | 47 | 0.060 |
Why?
|
| Blood Proteins | 1 | 2005 | 126 | 0.060 |
Why?
|
| Spheroids, Cellular | 2 | 2015 | 58 | 0.060 |
Why?
|
| Triazoles | 2 | 2017 | 130 | 0.060 |
Why?
|
| Electron Transport Complex I | 1 | 2024 | 31 | 0.060 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2025 | 140 | 0.060 |
Why?
|
| Prostate-Specific Antigen | 2 | 2016 | 233 | 0.060 |
Why?
|
| Hexokinase | 1 | 2024 | 25 | 0.050 |
Why?
|
| Neoplasms, Hormone-Dependent | 2 | 2014 | 92 | 0.050 |
Why?
|
| Receptors, Eph Family | 1 | 2024 | 22 | 0.050 |
Why?
|
| Receptor, EphA2 | 1 | 2024 | 28 | 0.050 |
Why?
|
| Cell Cycle Checkpoints | 2 | 2015 | 58 | 0.050 |
Why?
|
| Puberty | 1 | 2004 | 103 | 0.050 |
Why?
|
| Receptors, Antigen | 2 | 2014 | 33 | 0.050 |
Why?
|
| rap GTP-Binding Proteins | 1 | 2023 | 2 | 0.050 |
Why?
|
| Complement C7 | 1 | 2023 | 2 | 0.050 |
Why?
|
| Genomic Imprinting | 1 | 2024 | 127 | 0.050 |
Why?
|
| Alleles | 3 | 2017 | 1611 | 0.050 |
Why?
|
| Species Specificity | 2 | 2015 | 519 | 0.050 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2017 | 203 | 0.050 |
Why?
|
| Recombinational DNA Repair | 1 | 2023 | 17 | 0.050 |
Why?
|
| Chromosomes, Human | 2 | 2014 | 126 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 2006 | 514 | 0.050 |
Why?
|
| Rats | 3 | 2015 | 3388 | 0.050 |
Why?
|
| Sumoylation | 2 | 2014 | 35 | 0.050 |
Why?
|
| Hypoxia | 1 | 2005 | 246 | 0.050 |
Why?
|
| Age of Onset | 1 | 2025 | 609 | 0.050 |
Why?
|
| Azepines | 2 | 2014 | 61 | 0.050 |
Why?
|
| Metformin | 1 | 2025 | 157 | 0.050 |
Why?
|
| Database Management Systems | 1 | 2003 | 28 | 0.050 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2006 | 282 | 0.050 |
Why?
|
| Small Molecule Libraries | 1 | 2024 | 129 | 0.050 |
Why?
|
| Doxycycline | 2 | 2014 | 119 | 0.050 |
Why?
|
| Asthma | 1 | 2010 | 760 | 0.050 |
Why?
|
| Cell-Matrix Junctions | 1 | 2022 | 8 | 0.050 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2003 | 54 | 0.050 |
Why?
|
| Hedgehog Proteins | 2 | 2017 | 197 | 0.050 |
Why?
|
| Host-Pathogen Interactions | 1 | 2025 | 252 | 0.050 |
Why?
|
| Heart Failure | 1 | 2015 | 2161 | 0.050 |
Why?
|
| Tumor Escape | 1 | 2003 | 62 | 0.050 |
Why?
|
| Aurora Kinases | 2 | 2012 | 26 | 0.050 |
Why?
|
| Regeneration | 1 | 2024 | 205 | 0.050 |
Why?
|
| Fungal Proteins | 1 | 2003 | 130 | 0.050 |
Why?
|
| Integrins | 1 | 2022 | 88 | 0.050 |
Why?
|
| Drug Synergism | 2 | 2016 | 231 | 0.050 |
Why?
|
| Doxorubicin | 2 | 2014 | 288 | 0.050 |
Why?
|
| Peptides | 3 | 2013 | 826 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2012 | 121 | 0.050 |
Why?
|
| Adaptor Protein Complex sigma Subunits | 1 | 2021 | 2 | 0.050 |
Why?
|
| Genomic Instability | 2 | 2016 | 238 | 0.050 |
Why?
|
| Multigene Family | 2 | 2015 | 296 | 0.050 |
Why?
|
| Luciferases | 2 | 2012 | 126 | 0.040 |
Why?
|
| Folic Acid | 1 | 2024 | 276 | 0.040 |
Why?
|
| 1-Phosphatidylinositol 4-Kinase | 1 | 2021 | 9 | 0.040 |
Why?
|
| Organoids | 1 | 2024 | 282 | 0.040 |
Why?
|
| Discoidin Domain Receptor 2 | 1 | 2021 | 5 | 0.040 |
Why?
|
| Activin Receptors, Type II | 1 | 2021 | 30 | 0.040 |
Why?
|
| Alpha-Globulins | 1 | 2021 | 10 | 0.040 |
Why?
|
| Interleukin-2 | 1 | 2022 | 232 | 0.040 |
Why?
|
| Smad5 Protein | 1 | 2021 | 21 | 0.040 |
Why?
|
| Smad1 Protein | 1 | 2021 | 22 | 0.040 |
Why?
|
| Taxoids | 2 | 2012 | 69 | 0.040 |
Why?
|
| Zinc Finger E-box Binding Homeobox 2 | 1 | 2021 | 7 | 0.040 |
Why?
|
| Endothelium | 1 | 2021 | 62 | 0.040 |
Why?
|
| Interleukin-6 | 2 | 2014 | 405 | 0.040 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2021 | 34 | 0.040 |
Why?
|
| Acetylcholine | 1 | 2021 | 82 | 0.040 |
Why?
|
| Norepinephrine | 1 | 2021 | 152 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2014 | 751 | 0.040 |
Why?
|
| Lim Kinases | 1 | 2020 | 7 | 0.040 |
Why?
|
| Genes, Reporter | 2 | 2012 | 344 | 0.040 |
Why?
|
| Sphingomyelins | 1 | 2020 | 16 | 0.040 |
Why?
|
| Glycosphingolipids | 1 | 2020 | 10 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2025 | 1421 | 0.040 |
Why?
|
| Polyribosomes | 2 | 2010 | 23 | 0.040 |
Why?
|
| Cytoskeleton | 1 | 2021 | 167 | 0.040 |
Why?
|
| Biological Transport | 1 | 2021 | 327 | 0.040 |
Why?
|
| Cell Separation | 2 | 2012 | 219 | 0.040 |
Why?
|
| Gene Drive Technology | 1 | 2020 | 6 | 0.040 |
Why?
|
| Ubiquitin | 1 | 2021 | 128 | 0.040 |
Why?
|
| Genes, cdc | 1 | 2020 | 24 | 0.040 |
Why?
|
| Decision Making | 1 | 2006 | 665 | 0.040 |
Why?
|
| Pyrrolidines | 1 | 2020 | 42 | 0.040 |
Why?
|
| Jagged-2 Protein | 2 | 2011 | 5 | 0.040 |
Why?
|
| Neurotransmitter Agents | 1 | 2021 | 136 | 0.040 |
Why?
|
| CRISPR-Cas Systems | 1 | 2023 | 278 | 0.040 |
Why?
|
| Ceramides | 1 | 2020 | 46 | 0.040 |
Why?
|
| Matrix Metalloproteinases | 1 | 2020 | 58 | 0.040 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2021 | 163 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2020 | 132 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 1597 | 0.040 |
Why?
|
| Protein Transport | 1 | 2021 | 350 | 0.040 |
Why?
|
| Serotonin | 1 | 2021 | 203 | 0.040 |
Why?
|
| Chromosomal Instability | 1 | 2020 | 58 | 0.040 |
Why?
|
| Nucleotidyltransferases | 1 | 2020 | 46 | 0.040 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2003 | 402 | 0.040 |
Why?
|
| Antigens, CD | 2 | 2013 | 415 | 0.040 |
Why?
|
| Nervous System | 1 | 2020 | 120 | 0.040 |
Why?
|
| Glutamic Acid | 1 | 2021 | 200 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2013 | 950 | 0.040 |
Why?
|
| Probability | 1 | 2020 | 301 | 0.040 |
Why?
|
| Glycoproteins | 2 | 2013 | 331 | 0.040 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2020 | 74 | 0.040 |
Why?
|
| Genotype | 2 | 2016 | 2602 | 0.040 |
Why?
|
| Glypicans | 1 | 2020 | 40 | 0.040 |
Why?
|
| Myxococcus xanthus | 1 | 1999 | 2 | 0.040 |
Why?
|
| Lysogeny | 1 | 1999 | 9 | 0.040 |
Why?
|
| Actins | 1 | 2021 | 313 | 0.040 |
Why?
|
| Acetyltransferases | 1 | 2019 | 71 | 0.040 |
Why?
|
| MAP Kinase Kinase 7 | 1 | 2019 | 12 | 0.040 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2019 | 49 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2020 | 93 | 0.040 |
Why?
|
| Aerobiosis | 1 | 2019 | 13 | 0.040 |
Why?
|
| Graft vs Host Disease | 1 | 2024 | 625 | 0.040 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2022 | 512 | 0.040 |
Why?
|
| Receptor Cross-Talk | 1 | 2019 | 36 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 436 | 0.040 |
Why?
|
| DNA Primers | 2 | 2011 | 603 | 0.040 |
Why?
|
| Histocytochemistry | 1 | 2019 | 85 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 2006 | 881 | 0.040 |
Why?
|
| Stem Cell Niche | 1 | 2019 | 58 | 0.040 |
Why?
|
| RNA-Binding Proteins | 2 | 2014 | 536 | 0.040 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2018 | 34 | 0.040 |
Why?
|
| GTP-Binding Protein alpha Subunits, G12-G13 | 1 | 2018 | 2 | 0.040 |
Why?
|
| Neuroepithelial Cells | 1 | 2018 | 7 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2018 | 16 | 0.040 |
Why?
|
| Lentivirus | 1 | 2018 | 79 | 0.040 |
Why?
|
| Exocytosis | 1 | 2018 | 63 | 0.040 |
Why?
|
| Bacteriophages | 1 | 1999 | 86 | 0.040 |
Why?
|
| Lipid Metabolism | 1 | 2021 | 360 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 1999 | 422 | 0.030 |
Why?
|
| Acetylcholine Release Inhibitors | 1 | 2017 | 17 | 0.030 |
Why?
|
| Chemokines | 2 | 2008 | 129 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2021 | 504 | 0.030 |
Why?
|
| Web Browser | 1 | 2017 | 7 | 0.030 |
Why?
|
| Role | 1 | 2017 | 28 | 0.030 |
Why?
|
| Axons | 1 | 2020 | 372 | 0.030 |
Why?
|
| Chick Embryo | 1 | 2017 | 113 | 0.030 |
Why?
|
| Leucine | 1 | 2018 | 255 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2019 | 220 | 0.030 |
Why?
|
| Th17 Cells | 1 | 2018 | 93 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2018 | 403 | 0.030 |
Why?
|
| Receptors, OSM-LIF | 1 | 2017 | 6 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2018 | 330 | 0.030 |
Why?
|
| Prostatectomy | 1 | 2018 | 309 | 0.030 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2017 | 42 | 0.030 |
Why?
|
| Bone Morphogenetic Protein Receptors | 1 | 2017 | 11 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2020 | 788 | 0.030 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 2017 | 25 | 0.030 |
Why?
|
| Hydronephrosis | 1 | 2017 | 36 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2017 | 36 | 0.030 |
Why?
|
| Rho Guanine Nucleotide Exchange Factors | 1 | 2016 | 16 | 0.030 |
Why?
|
| Diet | 1 | 2024 | 1099 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2017 | 165 | 0.030 |
Why?
|
| Lipids | 1 | 2020 | 549 | 0.030 |
Why?
|
| Interleukin-1alpha | 1 | 2016 | 8 | 0.030 |
Why?
|
| Androstadienes | 1 | 2017 | 49 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2017 | 98 | 0.030 |
Why?
|
| Serum Amyloid P-Component | 1 | 2016 | 14 | 0.030 |
Why?
|
| Neural Stem Cells | 1 | 2018 | 130 | 0.030 |
Why?
|
| Biological Ontologies | 1 | 2016 | 8 | 0.030 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2016 | 29 | 0.030 |
Why?
|
| Nephrons | 1 | 2016 | 17 | 0.030 |
Why?
|
| Lysosomes | 1 | 2018 | 249 | 0.030 |
Why?
|
| Leukocyte Common Antigens | 1 | 2016 | 83 | 0.030 |
Why?
|
| Chemokine CXCL10 | 1 | 2016 | 50 | 0.030 |
Why?
|
| Neutrophil Infiltration | 1 | 2016 | 61 | 0.030 |
Why?
|
| User-Computer Interface | 1 | 2017 | 159 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2017 | 167 | 0.030 |
Why?
|
| Spinal Cord | 1 | 2017 | 243 | 0.030 |
Why?
|
| Ampulla of Vater | 1 | 2016 | 15 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 2016 | 110 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2017 | 178 | 0.030 |
Why?
|
| 5-Methylcytosine | 1 | 2016 | 30 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2016 | 151 | 0.030 |
Why?
|
| CCN Intercellular Signaling Proteins | 1 | 2015 | 1 | 0.030 |
Why?
|
| Cytosine | 1 | 2016 | 52 | 0.030 |
Why?
|
| Blastocyst | 1 | 2015 | 73 | 0.030 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2016 | 77 | 0.030 |
Why?
|
| Menstrual Cycle | 1 | 2016 | 34 | 0.030 |
Why?
|
| Bone and Bones | 1 | 2018 | 294 | 0.030 |
Why?
|
| Phorbols | 1 | 2015 | 5 | 0.030 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2015 | 15 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 2017 | 786 | 0.030 |
Why?
|
| Protein Domains | 1 | 2016 | 245 | 0.030 |
Why?
|
| Laser Capture Microdissection | 1 | 2015 | 8 | 0.030 |
Why?
|
| Tetrahydronaphthalenes | 1 | 2015 | 29 | 0.030 |
Why?
|
| Tubulin | 1 | 2015 | 68 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2015 | 82 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 2017 | 334 | 0.030 |
Why?
|
| Models, Molecular | 2 | 2011 | 1065 | 0.030 |
Why?
|
| Calcineurin | 1 | 2015 | 59 | 0.030 |
Why?
|
| Transcriptional Regulator ERG | 1 | 2015 | 39 | 0.030 |
Why?
|
| Valine | 1 | 2015 | 105 | 0.030 |
Why?
|
| Histological Techniques | 1 | 2015 | 19 | 0.030 |
Why?
|
| Tomography, Optical | 1 | 2015 | 6 | 0.030 |
Why?
|
| Microsatellite Repeats | 1 | 2016 | 230 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2015 | 87 | 0.030 |
Why?
|
| Mitochondrial Dynamics | 1 | 2015 | 48 | 0.030 |
Why?
|
| Pteridines | 1 | 2014 | 9 | 0.030 |
Why?
|
| Caco-2 Cells | 1 | 2015 | 86 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 6 | 1 | 2014 | 8 | 0.030 |
Why?
|
| Enzyme Induction | 1 | 2015 | 98 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 5089 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2017 | 510 | 0.030 |
Why?
|
| Synteny | 1 | 2015 | 77 | 0.030 |
Why?
|
| Cell Shape | 1 | 2015 | 68 | 0.030 |
Why?
|
| Kallikreins | 1 | 2014 | 27 | 0.030 |
Why?
|
| Tripartite Motif-Containing Protein 28 | 1 | 2014 | 14 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2018 | 788 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2015 | 282 | 0.030 |
Why?
|
| Anoikis | 1 | 2014 | 8 | 0.030 |
Why?
|
| Fibrosis | 1 | 2016 | 392 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2016 | 304 | 0.030 |
Why?
|
| Tripartite Motif Proteins | 1 | 2014 | 18 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2018 | 892 | 0.030 |
Why?
|
| Neoadjuvant Therapy | 1 | 2017 | 377 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2015 | 298 | 0.030 |
Why?
|
| Chromosome Breakpoints | 1 | 2014 | 81 | 0.030 |
Why?
|
| Chickens | 1 | 2014 | 284 | 0.030 |
Why?
|
| WNK Lysine-Deficient Protein Kinase 1 | 1 | 2014 | 13 | 0.030 |
Why?
|
| Gonanes | 1 | 2014 | 13 | 0.030 |
Why?
|
| Wnt4 Protein | 1 | 2014 | 22 | 0.030 |
Why?
|
| Zinc Fingers | 1 | 2014 | 108 | 0.030 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2014 | 37 | 0.030 |
Why?
|
| Japan | 1 | 2014 | 171 | 0.030 |
Why?
|
| Surface Plasmon Resonance | 1 | 2014 | 52 | 0.030 |
Why?
|
| E-Selectin | 1 | 2014 | 38 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2014 | 151 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2015 | 324 | 0.030 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2014 | 21 | 0.030 |
Why?
|
| Colony-Forming Units Assay | 1 | 2014 | 60 | 0.030 |
Why?
|
| Piperazines | 1 | 2015 | 245 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 1 | 2015 | 274 | 0.030 |
Why?
|
| Genome, Viral | 1 | 2014 | 153 | 0.030 |
Why?
|
| ROC Curve | 1 | 2015 | 566 | 0.030 |
Why?
|
| Hysterectomy | 1 | 2016 | 203 | 0.030 |
Why?
|
| Aspergillus oryzae | 1 | 2013 | 8 | 0.030 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2014 | 68 | 0.030 |
Why?
|
| Activins | 1 | 2013 | 71 | 0.030 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2015 | 208 | 0.030 |
Why?
|
| Hepatitis B virus | 1 | 2014 | 137 | 0.030 |
Why?
|
| Etoposide | 1 | 2014 | 112 | 0.030 |
Why?
|
| Choristoma | 1 | 2013 | 42 | 0.030 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2014 | 93 | 0.030 |
Why?
|
| Loss of Heterozygosity | 1 | 2014 | 122 | 0.030 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2013 | 24 | 0.030 |
Why?
|
| Bone Marrow Transplantation | 1 | 2016 | 575 | 0.030 |
Why?
|
| Janus Kinases | 1 | 2013 | 32 | 0.030 |
Why?
|
| Fluorouracil | 1 | 2014 | 135 | 0.030 |
Why?
|
| Hybrid Cells | 1 | 2013 | 78 | 0.030 |
Why?
|
| Calcium | 1 | 2018 | 1021 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 2013 | 64 | 0.030 |
Why?
|
| Antibodies | 1 | 2014 | 352 | 0.030 |
Why?
|
| Liposarcoma, Myxoid | 1 | 2013 | 3 | 0.030 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2013 | 150 | 0.020 |
Why?
|
| Epidemiologic Factors | 1 | 2013 | 8 | 0.020 |
Why?
|
| Integrin alpha6 | 1 | 2013 | 5 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2013 | 98 | 0.020 |
Why?
|
| snRNP Core Proteins | 1 | 2012 | 8 | 0.020 |
Why?
|
| Glucuronidase | 1 | 2013 | 29 | 0.020 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2013 | 23 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning Transmission | 1 | 2012 | 5 | 0.020 |
Why?
|
| Microsatellite Instability | 1 | 2013 | 36 | 0.020 |
Why?
|
| MutL Protein Homolog 1 | 1 | 2013 | 52 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2016 | 1294 | 0.020 |
Why?
|
| Models, Animal | 1 | 2015 | 454 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2013 | 258 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 57 | 0.020 |
Why?
|
| Hepacivirus | 1 | 2014 | 262 | 0.020 |
Why?
|
| BRCA2 Protein | 1 | 2012 | 50 | 0.020 |
Why?
|
| Respiratory Mucosa | 1 | 2013 | 97 | 0.020 |
Why?
|
| Th2 Cells | 1 | 2013 | 186 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2014 | 198 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2013 | 153 | 0.020 |
Why?
|
| Polycomb-Group Proteins | 1 | 2012 | 22 | 0.020 |
Why?
|
| BRCA1 Protein | 1 | 2012 | 77 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 2013 | 114 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 808 | 0.020 |
Why?
|
| Skin | 1 | 2015 | 515 | 0.020 |
Why?
|
| Blast Crisis | 1 | 2012 | 15 | 0.020 |
Why?
|
| Mesothelioma | 1 | 2013 | 90 | 0.020 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2013 | 124 | 0.020 |
Why?
|
| Mice, Hairless | 1 | 2012 | 30 | 0.020 |
Why?
|
| Centrosome | 1 | 2012 | 24 | 0.020 |
Why?
|
| Neurofibromatosis 1 | 1 | 2013 | 64 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2013 | 267 | 0.020 |
Why?
|
| Fallopian Tube Neoplasms | 1 | 2012 | 10 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2014 | 465 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2015 | 1070 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2013 | 250 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2015 | 1131 | 0.020 |
Why?
|
| Antigens, CD34 | 1 | 2012 | 99 | 0.020 |
Why?
|
| Myometrium | 1 | 2012 | 47 | 0.020 |
Why?
|
| Collagen Type IV | 1 | 2011 | 20 | 0.020 |
Why?
|
| Histones | 1 | 2015 | 506 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2011 | 56 | 0.020 |
Why?
|
| Estrogen Antagonists | 1 | 2012 | 94 | 0.020 |
Why?
|
| Deoxycytidine | 1 | 2012 | 81 | 0.020 |
Why?
|
| Schwann Cells | 1 | 2012 | 56 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2014 | 672 | 0.020 |
Why?
|
| Seizures | 1 | 2017 | 850 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2014 | 443 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2012 | 109 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2013 | 377 | 0.020 |
Why?
|
| Trastuzumab | 1 | 2012 | 143 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2015 | 661 | 0.020 |
Why?
|
| Oviducts | 1 | 2012 | 100 | 0.020 |
Why?
|
| Enzyme Stability | 1 | 2011 | 56 | 0.020 |
Why?
|
| Fibronectins | 1 | 2011 | 95 | 0.020 |
Why?
|
| Avian Leukosis Virus | 1 | 2011 | 12 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2015 | 1383 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 2014 | 641 | 0.020 |
Why?
|
| Acoustic Stimulation | 1 | 2011 | 75 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 588 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2014 | 639 | 0.020 |
Why?
|
| Smoking | 1 | 2016 | 894 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2014 | 565 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2014 | 724 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2011 | 157 | 0.020 |
Why?
|
| Methylation | 1 | 2011 | 198 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2013 | 739 | 0.020 |
Why?
|
| F-Box-WD Repeat-Containing Protein 7 | 1 | 2010 | 20 | 0.020 |
Why?
|
| Receptor, Insulin | 1 | 2010 | 59 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2010 | 93 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2013 | 394 | 0.020 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2011 | 44 | 0.020 |
Why?
|
| F-Box Proteins | 1 | 2010 | 32 | 0.020 |
Why?
|
| Aorta | 1 | 2014 | 503 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2011 | 396 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2011 | 622 | 0.020 |
Why?
|
| Drug Resistance | 1 | 2011 | 248 | 0.020 |
Why?
|
| Kidney | 1 | 2017 | 1262 | 0.020 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2010 | 39 | 0.020 |
Why?
|
| Benzimidazoles | 1 | 2011 | 133 | 0.020 |
Why?
|
| Cell Compartmentation | 1 | 2010 | 37 | 0.020 |
Why?
|
| Smoothened Receptor | 1 | 2010 | 30 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2016 | 530 | 0.020 |
Why?
|
| Ribosomes | 1 | 2010 | 125 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2013 | 1014 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 2035 | 0.020 |
Why?
|
| Random Allocation | 1 | 2010 | 420 | 0.020 |
Why?
|
| Everolimus | 1 | 2010 | 48 | 0.020 |
Why?
|
| Echocardiography | 1 | 2015 | 1095 | 0.020 |
Why?
|
| Lymphoma, AIDS-Related | 1 | 2009 | 25 | 0.020 |
Why?
|
| Organogenesis | 1 | 2010 | 80 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2011 | 343 | 0.020 |
Why?
|
| Genetic Therapy | 1 | 2014 | 681 | 0.020 |
Why?
|
| Aging | 1 | 2016 | 1194 | 0.020 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2009 | 24 | 0.020 |
Why?
|
| Serrate-Jagged Proteins | 1 | 2009 | 36 | 0.020 |
Why?
|
| Cell Death | 1 | 2010 | 234 | 0.020 |
Why?
|
| Proteasome Inhibitors | 1 | 2009 | 56 | 0.020 |
Why?
|
| Jagged-1 Protein | 1 | 2009 | 51 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2020 | 16782 | 0.020 |
Why?
|
| Interleukin-1 | 1 | 2009 | 131 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 1349 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2008 | 82 | 0.020 |
Why?
|
| Neuroblastoma | 1 | 2013 | 535 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2008 | 236 | 0.020 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2008 | 10 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2008 | 134 | 0.020 |
Why?
|
| Tretinoin | 1 | 2008 | 93 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2012 | 542 | 0.020 |
Why?
|
| Microspheres | 1 | 2007 | 69 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2015 | 1721 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 1738 | 0.020 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2006 | 2 | 0.020 |
Why?
|
| Cysteine-Rich Protein 61 | 1 | 2006 | 5 | 0.020 |
Why?
|
| Metalloproteases | 1 | 2006 | 14 | 0.020 |
Why?
|
| Synovial Membrane | 1 | 2006 | 26 | 0.020 |
Why?
|
| DNA Fingerprinting | 1 | 2006 | 104 | 0.020 |
Why?
|
| Angiogenic Proteins | 1 | 2006 | 15 | 0.020 |
Why?
|
| Immediate-Early Proteins | 1 | 2006 | 58 | 0.020 |
Why?
|
| HIV-1 | 1 | 2009 | 469 | 0.020 |
Why?
|
| Chromatography | 1 | 2005 | 35 | 0.010 |
Why?
|
| Trypsin | 1 | 2005 | 81 | 0.010 |
Why?
|
| Protein Sorting Signals | 1 | 2005 | 39 | 0.010 |
Why?
|
| Lectins | 1 | 2005 | 48 | 0.010 |
Why?
|
| Databases, Protein | 1 | 2005 | 59 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2008 | 744 | 0.010 |
Why?
|
| Osteoarthritis | 1 | 2006 | 97 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 3573 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2005 | 239 | 0.010 |
Why?
|
| Blood Coagulation | 1 | 2005 | 123 | 0.010 |
Why?
|
| Cadaver | 1 | 2004 | 112 | 0.010 |
Why?
|
| Phagocytosis | 1 | 2005 | 191 | 0.010 |
Why?
|
| Urinary Bladder | 1 | 2004 | 248 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2004 | 500 | 0.010 |
Why?
|
| RNA, Transfer, Asp | 1 | 1999 | 2 | 0.010 |
Why?
|
| Proviruses | 1 | 1999 | 19 | 0.010 |
Why?
|
| Viral Structural Proteins | 1 | 1999 | 39 | 0.010 |
Why?
|
| Genes, Viral | 1 | 1999 | 156 | 0.010 |
Why?
|
| United States | 1 | 2014 | 11159 | 0.010 |
Why?
|
| Risk Factors | 1 | 2013 | 10355 | 0.010 |
Why?
|
| Genes, Bacterial | 1 | 1999 | 217 | 0.010 |
Why?
|
| Genome, Bacterial | 1 | 1999 | 209 | 0.010 |
Why?
|
| Liver | 1 | 2005 | 1755 | 0.010 |
Why?
|